Suchergebnisse - "Perrone, Francesco"

PubPharm (19)

1

Brief Report : Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Piccirillo, M. | Chu, Q. | Bradbury, P. | +32

CommentIn: J Thorac Oncol. 2023 Jun;18(6):e67-e68. - PMID 37210188

2

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3) : a multicentre, open-label, randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2023

von Pignata, S. | Scambia, G. | Schettino, C. | +128

CommentIn: Lancet Oncol. 2023 Mar;24(3):201-203. - PMID 37052963

3

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cascinu, S. | Berardi, R. | Bianco, R. | +22

4

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer : The PACER Trial

enthalten in: Clinical colorectal cancer | 2020

von Piccirillo, M. | Avallone, A. | Carlomagno, C. | +18

5

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

enthalten in: Journal of translational medicine | 2020

von Perrone, F. | Piccirillo, M. | Ascierto, P. | +134

ErratumIn: J Transl Med. 2021 Oct 21;19(1):442. - PMID 34674735

6

The MITO CERV-2 trial : A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

enthalten in: Gynecologic oncology | 2019

von Pignata, S. | Scambia, G. | Lorusso, D. | +29

7

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11) : a randomised, open-label, phase 2 trial

enthalten in: The Lancet. Oncology | 2015

von Pignata, S. | Lorusso, D. | Scambia, G. | +21

CommentIn: Lancet Oncol. 2015 May;16(5):485-6. - PMID 25882985

8

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial)

enthalten in: BMC cancer | 2014

von Avallone, A. | Piccirillo, M. | Delrio, P. | +27

9

Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2 : the G-STEP trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2012

von Gridelli, C. | Gallo, C. | Morabito, A. | +75

10

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer : The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2010

von Gridelli, C. | Morabito, A. | Gebbia, V. | +17